Plasma IL-6 and YKL-40 levels did not differ between the cohort of newly diagnosed and recurrent GBM (IL-6, p = 0.49; YKL-40, p = 0.066;) (Cohort 2 and 3). The gene discussed is CHI3L1; the disease is glioblastoma.